Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen

Detalles Bibliográficos
Autores principales: Wang, Liang, Lyu, Yinfeng, Li, Yuqing, Li, Kunping, Wen, Hui, Feng, Chenchen, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637814/
https://www.ncbi.nlm.nih.gov/pubmed/37906268
http://dx.doi.org/10.18632/aging.205255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637814/
https://www.ncbi.nlm.nih.gov/pubmed/37906268
http://dx.doi.org/10.18632/aging.205255

Ejemplares similares